AlphaMark Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-138
| Closed | -$25K | – | 610 |
|
|
2021
Q2 | $25K | Sell |
138
-13,809
| -99% | -$2.5M | 0.01% | 306 |
|
|
2021
Q1 | $2.13M | Sell |
13,947
-2,068
| -13% | -$316K | 0.81% | 30 |
|
|
2020
Q4 | $2.5M | Sell |
16,015
-9,145
| -36% | -$1.43M | 0.96% | 29 |
|
|
2020
Q3 | $2.88M | Sell |
25,160
-5,119
| -17% | -$586K | 1.19% | 26 |
|
|
2020
Q2 | $3.4M | Buy |
30,279
+208
| +0.7% | +$23.3K | 1.47% | 18 |
|
|
2020
Q1 | $2.7M | Buy |
30,071
+590
| +2% | +$53K | 1.5% | 19 |
|
|
2019
Q4 | $3.19M | Buy |
+29,481
| New | +$3.19M | 1.33% | 26 |
|